rVSV-ZEBOV-GP vaccine

Published

dm+d

Unassigned

New Medicines

Ebola virus infection prevention

Information

Vaccine
Merck Sharp & Dohme (MSD)
Merck & Co (name used in US for MSD)

Development and Regulatory status

None
Phase III Clinical Trials
Pre-registration (filed)

Category

Vaccine based on the animal vesicular stomatitis virus (VSV) combined with a portion of the protein covering of the Ebola virus. developed by researchers at the Public Health Agency of Canada’s National Microbiology Laboratory.
Ebola virus is highly infectious and leads to a potentially fatal disease with fever, malaise, vomiting, mucosal and gastrointestinal bleeding, oedema, and hypotension. Mortality is 50-90% [3].
Ebola virus infection prevention
Parenteral